A detailed history of Sector Gamma As transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Sector Gamma As holds 27,583 shares of ALNY stock, worth $6.7 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
27,583
Previous 32,092 14.05%
Holding current value
$6.7 Million
Previous $6.14 Million 32.89%
% of portfolio
1.22%
Previous 1.56%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$146.51 - $198.2 $660,613 - $893,683
-4,509 Reduced 14.05%
27,583 $4.12 Million
Q4 2023

Feb 05, 2024

SELL
$151.41 - $196.57 $3.16 Million - $4.1 Million
-20,876 Reduced 39.41%
32,092 $6.14 Million
Q3 2023

Nov 06, 2023

BUY
$170.77 - $211.65 $4.25 Million - $5.27 Million
24,901 Added 88.72%
52,968 $9.38 Million
Q2 2023

Aug 09, 2023

BUY
$185.01 - $212.05 $125,436 - $143,769
678 Added 2.48%
28,067 $5.33 Million
Q1 2023

May 12, 2023

BUY
$182.66 - $235.53 $5 Million - $6.45 Million
27,389 New
27,389 $5.49 Million
Q3 2022

Nov 09, 2022

SELL
$138.54 - $232.0 $4.98 Million - $8.33 Million
-35,923 Reduced 83.85%
6,921 $1.39 Million
Q2 2022

Aug 05, 2022

SELL
$120.42 - $169.29 $1.98 Million - $2.78 Million
-16,407 Reduced 27.69%
42,844 $6.25 Million
Q1 2022

May 06, 2022

BUY
$127.18 - $173.91 $7.54 Million - $10.3 Million
59,251 New
59,251 $9.68 Million
Q3 2021

Oct 29, 2021

SELL
$169.75 - $207.73 $9.85 Million - $12.1 Million
-58,017 Closed
0 $0
Q2 2021

Aug 04, 2021

SELL
$128.63 - $176.89 $227,932 - $313,449
-1,772 Reduced 2.96%
58,017 $9.84 Million
Q1 2021

May 10, 2021

BUY
$126.83 - $175.69 $3.83 Million - $5.3 Million
30,174 Added 101.89%
59,789 $8.44 Million
Q4 2020

Feb 10, 2021

BUY
$122.97 - $147.0 $1.24 Million - $1.49 Million
10,124 Added 51.94%
29,615 $3.85 Million
Q3 2020

Nov 09, 2020

SELL
$121.19 - $165.49 $2.69 Million - $3.67 Million
-22,193 Reduced 53.24%
19,491 $2.84 Million
Q2 2020

Aug 07, 2020

SELL
$104.21 - $156.44 $1.32 Million - $1.99 Million
-12,700 Reduced 23.35%
41,684 $6.17 Million
Q1 2020

May 11, 2020

BUY
$93.12 - $133.99 $5.06 Million - $7.29 Million
54,384 New
54,384 $5.92 Million
Q4 2019

Feb 12, 2020

SELL
$74.51 - $124.23 $7.22 Million - $12 Million
-96,900 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$70.9 - $87.82 $1.77 Million - $2.2 Million
25,000 Added 34.77%
96,900 $7.79 Million
Q2 2019

Jul 31, 2019

BUY
$65.86 - $92.79 $4.74 Million - $6.67 Million
71,900 New
71,900 $5.22 Million
Q1 2019

May 13, 2019

SELL
$72.76 - $93.45 $4.32 Million - $5.55 Million
-59,437 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$62.67 - $88.33 $877,380 - $1.24 Million
14,000 Added 30.81%
59,437 $4.33 Million
Q3 2018

Nov 15, 2018

BUY
$87.52 - $122.67 $1.71 Million - $2.4 Million
19,567 Added 75.64%
45,437 $3.98 Million
Q3 2018

Nov 08, 2018

SELL
$87.52 - $122.67 $580,257 - $813,302
-6,630 Reduced 20.4%
25,870 $2.26 Million
Q2 2018

Aug 02, 2018

BUY
$88.31 - $107.8 $2.87 Million - $3.5 Million
32,500 New
32,500 $3.2 Million
Q1 2018

May 09, 2018

SELL
$115.92 - $148.54 $1.09 Million - $1.4 Million
-9,400 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$114.49 - $139.98 $1.08 Million - $1.32 Million
9,400
9,400 $1.19 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Sector Gamma As Portfolio

Follow Sector Gamma As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.